Author:
Balzano S.,Cappa M.,Migliari R.,Scarpa R. M.,Danielli E.,Campus G.,Pintus C.,Sica V.,Usai E.,Martino E.
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Reference15 articles.
1. Labrie F., Dupont A., Belanger A. Complete androgen blockade for the treatment of prostate cancer. In: De Vita V.T., Hellman S., Rosemberg S.A., (Eds.), Important advances in oncology. Lippincott Co., Philadelphia, 1985, p. 193.
2. Belanger A., Labrie F., Dupont A. Androgen levels in prostatic tissue of patients with carcinoma of the prostate treated with the combined therapy using a LHRH agonist and a pure antiandrogen. Eur. J. Cancer Clin. Oncol. 22: 742, 1986.
3. Labrie F., Dupont A., Belanger A., Giguere M., Lacoursiere Y., Emond J., Monfette G., Bergeron V. Combination therapy with flutamide and castration (LHRH agonist or orchiectomy) in advanced prostate cancer: a marked improvement in response and survival. J. Steroid Biochem. 23: 833, 1985.
4. Labrie F., Dupont A., Belanger A., Lacoursier Y., Raynaud Y.P., Husson J.M., Gareau J., Fazekas A.T.A., Sandow J., Monfette G., Girard J.G., Emond J., Houle J.G. New approach in the treatment of prostatic cancer: complete instead of only partial withdrawal of androgens. Prostate 4: 579, 1983.
5. Belager A., Dupont A., Labrie F. Inhibition of basal and adrenocorticotropin-stimulated plasma levels of adrenal androgens after treatment with an antiandrogen in castrated patients with prostatic cancer. J. Clin. Endocrinol. Metab. 59: 422, 1984.
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献